University of Miami Donates 1994 Ibogaine IND to HHS, MAPS Calls for Open Science — Multidisciplinary Association for Psychedelic Studies (MAPS)

Event summary

University of Miami gifted its 1994 ibogaine Investigational New Drug (IND) application to the U.S. federal government.
MAPS provided initial funding for the University of Miami ibogaine research program in the 1990s.
MAPS published its Ibogaine Investigator's Brochure in 2026, consolidating three decades of data.
MAPS emphasizes the need for ethical, rigorous science and equitable access in ibogaine research.

The big picture

The donation of the 1994 ibogaine IND to the federal government marks a significant step toward open science in psychedelic research. MAPS' involvement highlights the long-term commitment to ethical and rigorous science, emphasizing the need for transparent and evidence-based review. The strategic anomaly lies in the tension between historical data and current advancements, as well as the ethical obligations to source communities.

What we're watching

Regulatory Alignment: How the 1994 IND will integrate with current safety and sourcing data for ibogaine.
Community Impact: Whether U.S. demand for ibogaine will affect the iboga source communities in Gabon.
Research Collaboration: The pace at which other researchers contribute to the open science model for ibogaine.